Cited by 15Glioma Diagnosis and TreatmentOptical Imaging and Spectroscopy TechniquesNeurosurgical Procedures and Complications

5-Aminolevulinic acid–enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up

Open access
Strickland, Ben A., Wedemeyer, Michelle, Ruzevick, Jacob, Micko, Alexander, Shahrestani, Shane, Daneshmand, Siamak, Shiroishi, Mark S., Hwang, Darryl H. +3 more·2022·Journal of Neurosurgery

Abstract

OBJECTIVE: 5-Aminolevulinic acid (5-ALA)–enhanced fluorescence-guided resection of high-grade glioma (HGG) using microscopic blue light visualization offers the ability to improve extent of resection (EOR); however, few descriptions of HGG resection performed using endoscopic blue light visualization are currently available. In this report, the authors sought to describe their surgical experience and patient outcomes of 5-ALA–enhanced fluorescence-guided resection of HGG using primary or adjunctive endoscopic blue light visualization. METHODS: The authors performed a retrospective review of prospectively collected data from 30 consecutive patients who underwent 5-ALA–enhanced fluorescence-guided biopsy or resection of newly diagnosed HGG was performed. Patient demographic data, tumor characteristics, surgical technique, EOR, tumor fluorescence patterns, and progression-free survival were recorded. RESULTS: In total, 30 newly diagnosed HGG patients were included for analysis. The endoscope was utilized for direct 5-ALA–guided port-based biopsy (n = 9), microscopic to endoscopic (M2E; n = 18) resection, or exoscopic to endoscopic (E2E; n = 3) resection. All endoscopic biopsies of fluorescent tissue were diagnostic. 5-ALA–enhanced tumor fluorescence was visible in all glioblastoma cases, but only in 50% of anaplastic astrocytoma cases and no anaplastic oligodendroglioma cases. Gross-total resection (GTR) was achieved in 10 patients in whom complete resection was considered safe, with 11 patients undergoing subtotal resection. In all cases, endoscopic fluorescence was more avid than microscopic fluorescence. The endoscope offered the ability to diagnose and resect additional tumor not visualized by the microscope in 83.3% (n = 10/12) of glioblastoma cases, driven by angled lenses and increased fluorescence facilitated by light source delivery within the cavity. Mean volumetric EOR was 90.7% in all resection patients and 98.8% in patients undergoing planned GTR. No complications were attributable to 5-ALA or blue light endoscopy. CONCLUSIONS: The blue light endoscope is a viable primary or adjunctive visualization platform for optimization of 5-ALA–enhanced HGG fluorescence. Implementation of the blue light endoscope to guide resection of HGG glioma is feasible and ergonomically favorable, with a potential advantage of enabling increased detection of tumor fluorescence in deep surgical cavities compared to the microscope.

Integrity signals

Registry

Crossref · 10.3171/2022.1.jns212562

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endoscopes with angled lenses increase PpIX detection by providing focused light illumination within the cavity, resulting in the diagnosis and resection of glioblastomas that were not visible by the microscope in 10 out of 12 (83.3%) patients.

    “Endoscopes with angled lenses are able to increase PpIX detection by providing focused light illumination within the cavity, resulting in the diagnosis and resection of glioblastomas that were not visible by the microscope in 10 out of 12 (83.3%) patients [77].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Strickland, B. A., Wedemeyer, M., Ruzevick, J., Micko, A., Shahrestani, S., Daneshmand, S., Shiroishi, M. S., Hwang, D. H., Attenello, F., Chen, T., & Zada, G.
Affiliations
  • Neurological Surgery (US)
  • Urology, and
  • University of Southern California (US)
Venue
Journal of Neurosurgery
Published
2022-11-01
Volume
137
Issue
5
Pages
1378-1386
ISSN
  • 0022-3085 (ISSN-L)
  • 1933-0693
OpenAlex
W4220681458
Cited by
15
References
47
Citations by year
2026: 2 · 2025: 5 · 2024: 2 · 2023: 6
FWCI
2.02
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Journal of neurosurgery (publishedVersion, other-oa)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Optical Imaging and Spectroscopy Techniques
  • Health Sciences › Medicine › Neurology › Neurosurgical Procedures and Complications
Keywords
5-aminolevulinic acid, fluorescence-guided surgery, high-grade glioma, glioblastoma, anaplastic astrocytoma, anaplastic oligodendroglioma, extent of resection, gross total resection, progression-free survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review